In vivo and in vitro osteogenesis of stem cells induced by controlled release of drugs from microspherical scaffolds

Journal of Materials Chemistry

Volumn 20, Issue 41, 2010, Pages 9140-9148

  Shi, Xuetao ^a,c   Ren, Li ^a   Tian, Ming ^b   Yu, Jiakuo ^b   Huang, Wei ^a   Du, Chang ^a   Wang, Dong An ^a,c   Wang, Yingjun ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c Nanyang Technological University   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONATE; ALKALINE PHOSPHATASE ACTIVITY; BIOMEDICAL DEVICES; BONE DEFECT; BONE FORMATION; BONE MARROW MESENCHYMAL STEM CELLS; CONTROLLED RELEASE; CONTROLLED RELEASE SYSTEMS; DEXAMETHASONES; IMMUNOHISTOCHEMISTRY; IN-SITU; IN-VITRO; IN-VIVO; MATRIX; OSTEOCALCIN; OSTEOGENESIS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; PLGA/HA; POLY(LACTIC-CO-GLYCOLIC ACID); PROTEIN SECRETION; REAL TIME; TYPE I COLLAGEN;

ALUMINUM; BIOMATERIALS; BONE; CELL CULTURE; COLLAGEN; CYTOTOXICITY; DRUG PRODUCTS; GENE EXPRESSION; HYDROXYAPATITE; MICROSPHERES; PHOSPHATASES; SINTERING; STEM CELLS;

SCAFFOLDS;

EID: 77957905851     PISSN: 09599428     EISSN: 13645501     Source Type: Journal    
DOI: 10.1039/c0jm00976h     Document Type: Article

References (40)

1. U. Kneser D. J. Schaefer E. Polykandriotis R. E. Horch Tissue engineering of bone: The reconstructive surgeon's point of view J. Cell. Mol. Med. 2006 10 7 19
2. I. Jo J. M. Lee H. Suh H. Kim Bone tissue engineering using marrow stromal cells Biotechnol. Bioprocess Eng. 2007 12 48 53
3. J. A. Jadlowiec A. B. Celil J. O. Hollomger Bone tissue engineering: Recent advances and promising therapeutic agents Expert Opin. Biol. Th. 2003 3 409 423
4. C. A. Vacanti J. P. Vacanti Bone and cartilage reconstruction with tissue engineering approaches Otol. Clin. N. Am. 1994 27 263 276
5. B. D. Boyan C. H. Lohmann J. Romero Z. Schwartz Bone and cartilage tissue engineering Clin. Plast. Surg. 1999 26 629 645
6. J. E. Fleming Jr. C. N. Cornell G. F. Muschler Bone cells and matrices in orthopedic tissue engineering Orthop. Clin. North Am. 2000 31 357 374
7. D. W. Hutmacher Scaffolds in tissue engineeing bone and cartilage Biomaterials 2000 21 2529 2543
8. A. Uccelli L. Moretta V. Pistoia Mesenchymal stem cells in health and disease Nat. Rev. Immunol. 2008 8 726 736
9. S. Cartmell Controlled release scaffolds for bone tissue engineering J. Pharm. Sci. 2009 98 430 441
10. K. Park J. S. Park D. G. Woo H. N. Yang H.-M. Chung K. H. Park The use of chondrogenic differetiaiton drugs to induce stem cell differetiation using double bead microsphere structure Biomaterials 2008 29 2490 2500
11. X. Shi Y. Wang R. R. Varshney L. Ren Y. Gong D.-A. Wang Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cell in vitro Eur. J. Pharm. Sci. 2010 39 59 67
12. H. Kim H. Suh S. A. Jo H. W. Kim J. M. Lee E. H. Kim et al. In vivo bone formation by human marrow stromal cells in biodegradable scaffolds that release dexamethasone and ascorbate-2-phosphate Biochem. Biophys. Res. Commun. 2005 332 1053 1060
13. J. E. Fisher M. J. Rogers J. M. Halasy S. P. Luckman D. E. Hughes P. J. Masarachia et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalionate pathway, prevents inhibition of osteoclasts formation, bone resorption, and kinase activation in vitro Proc. Natl. Acad. Sci. U. S. A. 1999 96 133 139
14. K. L. Kavanagh K. Guo J. E. Dunford X. Wu S. Knapp F. H. Ebetino et al. The molecular mechanism of nitrogen-containing bisphophonates as antiosteoporosis drugs Proc. Natl. Acad. Sci. U. S. A. 2006 103 7829 7834
15. H. Fleisch Bisphosphonates: mechanisms of action Endocr. Rev. 1998 19 80 100
16. S. Walsh G. R. Jordan C. Jefferiss K. Stewart J. N. Beresford High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro:Relevance to glucocorticoid-induced osteoporosis Rheumatology 2001 40 74 83
17. X. Shi Y. Wang L. Ren N. Zhao Y. Gong D.-A. Wang Novel mesoporous silica based antibiotic releasing scaffold for bone repair Acta Biomater. 2009 5 1697 1707
18. X. Shi Y. Wang L. Ren W. Huang D.-A. Wang A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications Int. J. Pharm. 2009 373 85 92
19. X. Shi Y. Wang R. R. Varshney L. Ren F. Zhang D.-A. Wang In vitro osteogenesisi of synovium stem cells induced by controlled release of bisphosphate additives from microsperical mesoporous silica composite Biomaterials 2009 30 3996 4005
20. E. Boanini M. Gazzano K. Rubini A. Bigi Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure Adv. Mater. 2007 19 2499 2502
21. R. G. G. Russell N. B. Watts F. H. Ebetino M. J. Rogers Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy Osteoporosis Int. 2008 19 733 759
22. H. Ohgushi M. Okumura S. Tamai E. C. Shors A. I. Caplan Marrow cell induced osteogenesis in porous hydroxyapatite and tricalcium phosphate: A comparative histomorphometric study of ectopic bone formation J. Biomed. Mater. Res. 1990 24 1563 1570
23. J. Kuljanin I. Janković J. Nedeljković D. Prstojević V. Marinković Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions J. Pharm. Biomed. Anal. 2002 28 1215 1220
24. M. S. Iqbal M. A. Shad M. W. Ashraf M. Bilal M. Saeed Development and validation of an HPLC method for the determination of dexamethasone, dexamethasone sodium phosphate and chloramphenicol in presence of each other in pharmaceutical preparations Chromatographia 2006 64 219 222
25. W. Liu L. Cui Y. Cao Recent advances in tissue engineering of cartilage, bone and tendon Curr. Opin. Orthop. 2004 15 364 368
26. U. Meyer, H. P. Wiesmann, Bone and cartilage engineering, Heidelberg: Springer, 2006; 7-43
27. K. Na S. W. Kim B. K. Sun D. G. Woo H. N. Yang H. M. Chung et al, Osteogenic differetiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2(BMP-2) Biomaterials 2007 28 2631 2637
28. Y. Sakaguchi I. Sekiya K. Yagishita T. Muneta Comparison of human stem cells derived from various mesenchymal tissue: superiority of synovium as a cell source Arthritis Rheum. 2005 52 2521 2529
29. X. Shi Y. Wang L. Ren C. Lai Y. Gong D.-A. Wang A novel hydrophilic poly(lactide-co-glycolide)/lecithin hybrid microspheres sintered scaffold for bone repair J. Biomed. Mater. Res. 2010 92A 963 972
30. P. X. Ma J.-W. Choi Biodegradable polymer scaffolds with well-defined interconnected spherical pore network Tissue Eng. 2001 7 23 3
31. H. Kim H. W. Kim H. Suh Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells Biomaterials 2003 24 4671 4679
32. X. Shi Y. Wang L. Ren Y. Gong D.-A. Wang Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications Pharm. Res. 2009 26 422 430
33. G-I Im S. A. Qureshi J. Kenney H. E. Rubash A. S. Shanbhag Osteoblast proliferation and maturation by bisphosphonates Biomaterials 2004 25 4105 4115
34. F. von Knoch C. Jaquiery M. Kowalsky S. Schaeren C. Alabre I. Martin et al. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells Biomaterials 2005 26 6941 6949 (Pubitemid 41095518)
35. D.-A. Wang C. G. Williams F. Yang N. Cher H. Lee J. H. Elisseeff Bioresponsive phosphoester hydrogels for bone tissue engineering Tissue Eng. 2005 11 201 213
36. J. E. Phillips C. A. Gersbach A. M. Wojtowicz A. J. García Glucocorticoid-induced osteogenesis is negatively regulated by runx2/cbfa1 serine phosphorylation J. Cell Sci. 2006 119 581 591
37. M. Borden M. Attawia Y. Khan C. T. Laurencin Tissue engineering microsphere-based matrices for bone repair: design and evaluation Biomaterials 2002 23 551 559
38. E. Jabbarzadeh T. Jiang M. Deng L. S. Nair Y. M. Khan C. T. Laurencin Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering Biotechnol. Bioeng. 2007 98 1094 1102
39. B. Palazzo M. Iafisco M. Laforgia N. Margiotta G. Natile C. L. Bianchi et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties Adv. Funct. Mater. 2007 17 2180 2188
40. M.-W. Chang E. Stride M. Edirisinghe A new method for the preparation of monoporous hollow microsphere Langmuir 2010 26 5115 5121